UNIVAX STAPH VACCINE PHASE II TRIALS UNDER WAY
Executive Summary
UNIVAX STAPH VACCINE PHASE II TRIALS UNDER WAY, Univax Clinical Operations Director Mitchell Katz, PhD, told the Cambridge Healthtech Second International Conference on Vaccines: New Technologies and Applications in Alexandria, Va. March 23. The Phase II trial began in August 1993 and just completed enrollment; the study will run for a year, testing the Staphylococcus aureus types 5 and 8 vaccine, Katz said.